Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial

NCT06485154 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

HIV Prevention

Interventions

DRUG: TLD - Tenofovir Disoproxil Fumarate / Lamivudine / Dolutegravir

Sponsor

University of Witwatersrand, South Africa

Collaborators

[object Object]